Sonida Senior Living Inc Revenue Growth Rates (SNDA), Current and Historic Growth - CSIMarket
CSIMarket
 


Sonida Senior Living Inc   (NYSE: SNDA)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

SNDA's Revenue Growth by Quarter and Year

Sonida Senior Living Inc 's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/SNDA/growth
https://api.csimarket.com/api/v1/companies/SNDA/fundamentals
https://api.csimarket.com/api/v1/companies/SNDA/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
SNDA Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 210.20
2nd Quarter June 207.65
1st Quarter March 122.63
FY 540.48

SNDAs Annual Revenue
Sonida Senior Living Inc 's Revenue in the fiscal year 2025 $ 381.14 millions
Sonida Senior Living Inc 's Revenue in the fiscal year 2024 $ 304.33 millions
Sonida Senior Living Inc 's Revenue in the fiscal year 2023 $ 255.32 millions
Sonida Senior Living Inc 's Revenue in the fiscal year 2022 $ 238.43 millions
Sonida Senior Living Inc 's Revenue in the fiscal year 2021 $ 234.72 millions




SNDA Revenue third quarter 2026 Y/Y Growth Comment
Sonida Senior Living Inc achieved in the third quarter 2026, above Company average Revenue surge of 114.4% year on year, to $ 210.20 millions.

Looking into third quarter 2026 results within Healthcare Facilities industry 15 other companies have achieved higher Revenue growth. While Sonida Senior Living Inc ' s Revenue doubling of 114.4% ranks overall at the positon no. 1783 in the third quarter 2026.




SNDA Revenue ( Y/Y Growth %) 2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 114.4 %
2nd Quarter June 122.01 %
1st Quarter March 33.41 %
FY   -

Financial Statements
Sonida Senior Living Inc 's third quarter 2026 Revenue $ 210.20 millions SNDA's Income Statement
Sonida Senior Living Inc 's third quarter 2025 Revenue $ 98.04 millions Quarterly SNDA's Income Statement


SNDA Revenue (Quarter on Quarter Growth %)

2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 1.23 %
2nd Quarter June 69.33 %
1st Quarter March 25.57 %
FY (Year on Year)   -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #16
Healthcare Sector #281
Overall #1783

Revenue Y/Y Growth Statistics
High Average Low
167.14 % 11.65 % -38.85 %
(Mar 31 2014)   (Dec 31 2021)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #16
Healthcare Sector #281
Overall #1783
Revenue Y/Y Growth Statistics
High Average Low
167.14 % 11.65 % -38.85 %
(Mar 31 2014)   (Dec 31 2021)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Sonida Senior Living Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
69.33 % 2.58 % -23.14 %
(Jun 30 2026)  


SNDA's III. Quarter Q/Q Revenue Comment
Sonida Senior Living Inc achieved in the III. Quarter 2026 below company average Revenue growth of 1.23% quarter on quarter, to $ 210.20 millions.

Within Healthcare Facilities industry Sonida Senior Living Inc achieved highest sequential Revenue growth. While Sonida Senior Living Inc 's Revenue growth quarter on quarter, overall rank is 175.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #1
Healthcare Sector #51
Overall #175
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #1
Healthcare Sector #51
Overall #175
Revenue Q/Q Growth Statistics
High Average Low
69.33 % 2.58 % -23.14 %
(Jun 30 2026)  


SNDA's III. Quarter Q/Q Revenue Comment
Sonida Senior Living Inc achieved in the III. Quarter 2026 below company average Revenue growth of 1.23% quarter on quarter, to $ 210.20 millions.

Within Healthcare Facilities industry Sonida Senior Living Inc achieved highest sequential Revenue growth. While Sonida Senior Living Inc 's Revenue growth quarter on quarter, overall rank is 175.


Sonida Senior Living Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)
12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 638.13
Y / Y Revenue Growth (TTM) 69.98 %
Year on Year Revenue Growth Overall Ranking # 521
Seqeuential Revenue Change (TTM) 21.32 %
Seq. Revenue Growth (TTM) Overall Ranking # 1783


Cumulative Revenue growth Comment
Sonida Senior Living Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 69.98% year on year, to $ 638 millions if the fiscal year would have ended in Sep 30 2026.
Sonida Senior Living Inc 's trailing twelve months Revenue growth was higher than company's average 11.65% and higher than 49.37% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 21.32 % from $525.97 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 11.65%.

In the Healthcare sector 122 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 502 to 521.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 16
Healthcare Sector # 123
Overall # 521

Revenue TTM Y/Y Growth Statistics
High Average Low
167.14 %
11.65 %
-38.85 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 16
Sector # 281
S&P 500 # 1783
Cumulative Revenue growth Comment
Sonida Senior Living Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 69.98% year on year, to $ 638 millions if the fiscal year would have ended in Sep 30 2026.
Sonida Senior Living Inc 's trailing twelve months Revenue growth was higher than company's average 11.65% and higher than 49.37% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 21.32 % from $525.97 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 11.65%.
The momentum is even more impressive from twelve months ended Jun 30 2026 exhibited at 21.32 % increase from $525.97 millions in the period from Jun 30 2026 to Sep 30 2025.

In the Healthcare sector 122 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 502 to 521.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 16
Healthcare Sector # 123
Overall # 521

Revenue TTM Y/Y Growth Statistics
High Average Low
167.14 %
11.65 %
-38.85 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 16
Sector # 281
S&P 500 # 1783




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SNDA's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Bridgebio Pharma Inc 192.60%$ 192.602 millions
Bicycle Therapeutics Plc190.24%$ 190.242 millions
Gossamer Bio Inc 189.09%$ 189.085 millions
Alpha Cognition Inc.173.75%$ 173.751 millions
Eton Pharmaceuticals Inc 165.04%$ 165.042 millions
Sera Prognostics Inc 162.50%$ 162.500 millions
Volitionrx Limited157.28%$ 157.283 millions
Neuraxis Inc 149.92%$ 149.922 millions
Pluri Inc 140.19%$ 140.190 millions
Camp4 Therapeutics Corporation138.87%$ 138.868 millions
Sonida Senior Living Inc 114.40%$ 114.402 millions
Verastem Inc 113.59%$ 113.592 millions
Hyperfine Inc 109.27%$ 109.270 millions
Pelthos Therapeutics Inc 107.87%$ 107.872 millions
Co diagnostics Inc 94.58%$ 94.580 millions
Autolus Therapeutics Plc94.57%$ 94.574 millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________93.02%$ 93.022 millions
Keros Therapeutics Inc 88.77%$ 88.766 millions
Profound Medical Corp 85.86%$ 85.857 millions
Vivosim Labs Inc 82.14%$ 82.143 millions
Syndax Pharmaceuticals Inc 81.59%$ 81.592 millions
Iovance Biotherapeutics inc 80.07%$ 80.074 millions
Rhythm Pharmaceuticals Inc 79.59%$ 79.594 millions
Omniab Inc 78.34%$ 78.339 millions
Aclarion Inc 78.09%$ 78.086 millions
Personalis Inc 76.59%$ 76.585 millions
Delcath Systems Inc 76.05%$ 76.047 millions
Mobia Medical Inc 73.28%$ 73.280 millions
Wave Life Sciences Ltd 72.95%$ 72.950 millions
Igc Pharma Inc 71.73%$ 71.728 millions


About Sonida Senior Living Inc Revenue Growth Rates (SNDA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Sonida Senior Living Inc (CIK 1043000).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001043000-26-000040
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Sonida Senior Living Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.